VERTEX PHARMACEUTICALS INC / MA (VRTX) Shareholders’ equity 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) shareholders’ equity at each fiscal year-end, per SEC filings.
$18.7BFY2025 · since FY2016: $1.2B → $18.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $18.7B | +13.7% |
| FY2024 | $16.4B | -6.7% |
| FY2023 | $17.6B | +26.4% |
| FY2022 | $13.9B | +37.7% |
| FY2021 | $10.1B | +16.3% |
| FY2020 | $8.7B | +42.8% |
| FY2019 | $6.1B | +37.2% |
| FY2018 | $4.4B | +118.6% |
| FY2017 | $2.0B | +75.4% |
| FY2016 | $1.2B | — |
Source: SEC XBRL filings · For reference only · Not investment advice